๐‚๐š๐ฌ-๐‚๐‹๐Ž๐•๐„๐‘ ๐ข๐ฌ ๐ฆ๐จ๐ซ๐ž ๐ญ๐ก๐š๐ง ๐ ๐ž๐ง๐ž ๐ž๐๐ข๐ญ๐ข๐ง๐ , ๐ข๐ญโ€™๐ฌ ๐š ๐›๐ฎ๐ฌ๐ข๐ง๐ž๐ฌ๐ฌ ๐š๐๐ฏ๐š๐ง๐ญ๐š๐ ๐ž.
At BioProcess International Fall Digital Week 2025, Demeetra presented: โ€œ๐‘ผ๐’๐’๐’๐’„๐’Œ๐’Š๐’๐’ˆ ๐’•๐’‰๐’† ๐‘ญ๐’–๐’•๐’–๐’“๐’† ๐’๐’‡ ๐‘ฉ๐’Š๐’๐’๐’๐’ˆ๐’Š๐’„๐’” ๐‘ด๐’‚๐’๐’–๐’‡๐’‚๐’„๐’•๐’–๐’“๐’Š๐’๐’ˆ: ๐‘ช๐’‚๐’”-๐‘ช๐‘ณ๐‘ถ๐‘ฝ๐‘ฌ๐‘น ๐’‡๐’๐’“ ๐‘ฉ๐’Š๐’ˆ ๐‘ท๐’‰๐’‚๐’“๐’Ž๐’‚ & ๐‘จ๐’…๐’—๐’‚๐’๐’„๐’†๐’… ๐‘ท๐’Š๐’‘๐’†๐’๐’Š๐’๐’†๐’”.โ€
Jack Crawford, CEO, outlines how Cas-CLOVER tackles two challenges facing Big Pharma today: securing robust commercial FTO and achieving scalable, high-efficiency performance beyond CRISPR and ZFNs. Then Corey Brizzee, PhD Brizzee, Ph.D., shares data-driven results on host cell optimization and multiplexed HCP removalโ€”showing how Cas-CLOVER is transforming cell line development from R&D to GMP scale. With flexible, milestone-free licensing, Cas-CLOVER helps biopharma teams accelerate innovation and ROI.

Access the full webcast recording here to watch on demand.

Demeetra provides integrated genome engineering platforms, and products, backed by deep technical expertise.

Contact us to learn how our differentiated IP, flexible access models, and internal know-how can support adoption from discovery through bioprocessing and commercial use.

Buy Products
Schedule A Call